|
10 Aug 2025 |
CCL Products
|
Consensus Share Price Target
|
864.35 |
911.70 |
- |
5.48 |
buy
|
|
|
|
|
07 Aug 2025
|
CCL Products
|
Axis Direct
|
864.35
|
970.00
|
862.65
(0.20%)
|
12.22 |
Buy
|
|
|
With a 12% upside from the CMP, we maintain our BUY rating on the stock.
|
|
07 Aug 2025
|
CCL Products
|
IDBI Capital
|
864.35
|
849.00
|
862.65
(0.20%)
|
Target met |
Hold
|
|
|
CCL Products Q1FY26 profitability was below our expectations. Sales grew 37% YoY to Rs10.7bn, driven by 9-10% YoY volume growth and 27-28% YoY increase in realization due to improved coffee blends. Gross margin contracted by 543bps YoY to 32.6%, driven by higher input cost. Consequently, EBITDA margin contracted by 178bps YoY to 15.1%. EBITDA grew 22% YoY to Rs1.6bn, driven by a favorable product mix in B2B and growth in the B2C category. PAT increased by 1% YoY to Rs724mn. CCL maintained its volume and EBITDA growth guidance of 10-20% and 15-20%, respectively. Management expects some price...
|
|
07 May 2025
|
CCL Products
|
Axis Direct
|
864.35
|
800.00
|
772.60
(11.88%)
|
Target met |
Buy
|
|
|
With a 15% upside from the CMP, we maintain our BUY rating on the stock
|
|
07 May 2025
|
CCL Products
|
Keynote Capitals Ltd
|
864.35
|
1126.00
|
772.60
(11.88%)
|
30.27 |
Buy
|
|
|
Quarterly Update Q4FY25
|
|
06 May 2025
|
CCL Products
|
IDBI Capital
|
864.35
|
738.00
|
772.60
(11.88%)
|
Target met |
Hold
|
|
|
|
|
07 Feb 2025
|
CCL Products
|
Keynote Capitals Ltd
|
864.35
|
1146.00
|
654.35
(32.09%)
|
32.59 |
Buy
|
|
|
Quarterly Update Q3FY25
|
|
07 Feb 2025
|
CCL Products
|
Axis Direct
|
864.35
|
730.00
|
654.35
(32.09%)
|
Target met |
Buy
|
|
|
With a 13% upside from the CMP, we maintain our BUY rating on the stock.
|
|
07 Feb 2025
|
CCL Products
|
IDBI Capital
|
864.35
|
698.00
|
654.35
(32.09%)
|
Target met |
Hold
|
|
|
|
|
28 Jan 2025
|
CCL Products
|
CD Equisearch
|
864.35
|
681.00
|
599.45
(44.19%)
|
Target met |
Accumulate
|
|
|
|
|
11 Nov 2024
|
CCL Products
|
Keynote Capitals Ltd
|
864.35
|
1222.00
|
713.05
(21.22%)
|
41.38 |
Buy
|
|
|
Quarterly Update Q2FY25
|
|
11 Nov 2024
|
CCL Products
|
BP Wealth
|
864.35
|
|
713.05
(21.22%)
|
|
Results Update
|
|
|
|
|
07 Nov 2024
|
CCL Products
|
IDBI Capital
|
864.35
|
734.00
|
691.70
(24.96%)
|
Target met |
Hold
|
|
|
|
|
07 Nov 2024
|
CCL Products
|
Axis Direct
|
864.35
|
820.00
|
701.40
(23.23%)
|
Target met |
Buy
|
|
|
With a 14% upside from the CMP, we maintain our BUY rating on the stock.
|
|
09 Sep 2024
|
CCL Products
|
Keynote Capitals Ltd
|
864.35
|
1221.00
|
747.05
(15.70%)
|
41.26 |
Buy
|
|
|
Initiating Coverage Report
|
|
09 Aug 2024
|
CCL Products
|
Axis Direct
|
864.35
|
760.00
|
659.85
(30.99%)
|
Target met |
Buy
|
|
|
With a 15% upside from the CMP, we maintain our BUY rating on the stock.
|
|
14 May 2024
|
CCL Products
|
Axis Direct
|
864.35
|
670.00
|
563.40
(53.42%)
|
Target met |
Buy
|
|
|
With a 17% upside from the CMP, we maintain our BUY rating on the stock.
|
|
14 May 2024
|
CCL Products
|
IDBI Capital
|
864.35
|
582.00
|
563.40
(53.42%)
|
Target met |
Hold
|
|
|
|
|
30 Mar 2024
|
CCL Products
|
CD Equisearch
|
864.35
|
645.00
|
586.30
(47.42%)
|
Target met |
Hold
|
|
|
|
|
07 Feb 2024
|
CCL Products
|
Axis Direct
|
864.35
|
720.00
|
667.35
(29.52%)
|
Target met |
Buy
|
|
|
With a 12% upside from the CMP, we maintain our BUY rating on the stock.
|
|
08 Nov 2023
|
CCL Products
|
BP Wealth
|
864.35
|
|
635.85
(35.94%)
|
|
Results Update
|
|
|
|